New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
Published: June 24, 2018 at 02:00AM
from NYT Health https://ift.tt/2toIJWM
New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
Published: June 24, 2018 at 02:00AM
from NYT Health https://ift.tt/2toIJWM